Clinical trial
A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART
NCT00002392 · Rockefeller University, Other · Completed
Key facts
| NCT number | NCT00002392 |
|---|---|
| Title | A Study of Thalidomide in HIV-Infected Patients Who Are Receiving HAART |
| Official title | A Study to Investigate the Potential of Thalidomide Treatment to Enhance Immune Responses in HIV-Infected Individuals Who Are Receiving Highly Active Antiretroviral Therapy. |
| Lead sponsor | Rockefeller University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Thalidomide |
| Enrollment | 12 |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: